Office of the Director, National Institutes of Health; Notice of Meetings, 12310 [2020-04163]
Download as PDF
<![CDATA[
12310
Federal Register / Vol. 85, No. 41 / Monday, March 2, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the Advisory Committee on
Research on Women’s Health.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meetings.
The meetings will also be videocast
and can be accessed from the NIH
Videocasting and Podcasting website
(https://videocast.nih.gov/).
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: April 21, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: Director’s Report and Scientific
Presentations.
Place: National Institutes of Health, Porter
Neuroscience Center, Building 35A,
Conference Room 620/630, 35 Center Drive,
Bethesda, MD 20892.
Contact Person: Elizabeth Spencer, R.N.,
Deputy Director, Office of Research on
Women’s Health, Executive Secretary,
ACRWH, National Institutes of Health, 6707
Democracy Blvd., Room 7W444, Bethesda,
MD 20817, (301) 402–1770,
elizabeth.spencer@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meetings. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
VerDate Sep<11>2014
18:10 Feb 28, 2020
Jkt 250001
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
orwh.od.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–04163 Filed 2–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given for the meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
National Advisory Council (CSAP NAC)
on March 17, 2020.
The Council was established to advise
the Secretary, Department of Health and
Human Services (HHS); the Assistant
Secretary for Mental Health and
Substance Use, SAMHSA; and Director,
CSAP concerning matters relating to the
activities carried out by and through the
Center and the policies respecting such
activities.
The meeting will be open to the
public and will include the discussion
of the Evidence-Based Practices
Resource Center; new SAMHSA
publications; adolescent prevention
programs/activities; and Fostering
Healthy Mental, Emotional, and
Behavioral Development. The meeting
will also include updates on CSAP
program developments. The meeting
will be held in Rockville, Maryland.
Attendance by the public on-site will be
limited to the space available. Interested
persons may present data, information,
or views, orally or in writing, on issues
pending before the Council. Written
submissions should be forwarded to the
contact person on or before one week
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
prior to the meeting. Oral presentations
from the public will be scheduled at the
conclusion of the meeting. Individuals
interested in making oral presentations
should notify the contact on or before
one week prior to the meeting. Five
minutes maximum will be allotted for
each presentation.
To attend onsite, submit written or
brief oral comments, or request special
accommodations for persons with
disabilities, please register at the
SAMHSA Committees’ website, https://
snacregister.samhsa.gov/
MeetingList.aspx, or communicate with
the CSAP Council’s Designated Federal
Officer (see contact information below).
Substantive program information may
be obtained after the meeting by
accessing the SAMHSA Committee
website, https://www.samhsa.gov/
about-us/advisory-councils, or by
contacting the Designated Federal
Officer.
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention National Advisory
Council.
Date/Time/Type: March 17, 2020,
from 9:30a.m. to 5:00p.m. EDT: (OPEN).
Place: SAMHSA, 5600 Fishers Lane,
Room 5N54, Rockville, MD 20852,
Adobe Connect webcast: https://
samhsa-csap.adobeconnect.com/nac/.
Contact: Matthew J. Aumen,
Designated Federal Officer, SAMHSA
CSAP NAC, 5600 Fishers Lane,
Rockville, MD 20852, Telephone: 240–
276–2440, Fax: 301–480–8480, Email:
matthew.aumen@samhsa.hhs.gov.
Dated: February 26, 2020.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2020–04212 Filed 2–28–20; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of HHS-Certified
Laboratories and Instrumented Initial
Testing Facilities Which Meet Minimum
Standards To Engage in Urine and Oral
Fluid Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) notifies federal
agencies of the laboratories and
Instrumented Initial Testing Facilities
SUMMARY:
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 85, Number 41 (Monday, March 2, 2020)]
[Notices]
[Page 12310]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04163]
[[Page 12310]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meetings
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the Advisory Committee
on Research on Women's Health.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meetings.
The meetings will also be videocast and can be accessed from the
NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Advisory Committee on Research on Women's
Health.
Date: April 21, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: Director's Report and Scientific Presentations.
Place: National Institutes of Health, Porter Neuroscience
Center, Building 35A, Conference Room 620/630, 35 Center Drive,
Bethesda, MD 20892.
Contact Person: Elizabeth Spencer, R.N., Deputy Director, Office
of Research on Women's Health, Executive Secretary, ACRWH, National
Institutes of Health, 6707 Democracy Blvd., Room 7W444, Bethesda, MD
20817, (301) 402-1770, [email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meetings. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://orwh.od.nih.gov/, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: February 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-04163 Filed 2-28-20; 8:45 am]
BILLING CODE 4140-01-P
